ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABAX Abaxis, Inc. (delisted)

83.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Abaxis, Inc. (delisted) NASDAQ:ABAX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 83.00 82.85 83.01 0 01:00:00

Abaxis to Participate in BTIG's Inaugural Snowbird Medical Technology and Diagnostics Conference

12/03/2014 12:00pm

PR Newswire (US)


Abaxis, Inc. (delisted) (NASDAQ:ABAX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Abaxis, Inc. (delisted) Charts.

UNION CITY, Calif., March 12, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, Chief Operations Officer, will participate in BTIG's Inaugural Snowbird Medical Technology and Diagnostics Conference on Tuesday, March 18, 2014.

The conference is being held from March 18-20, 2014 at The Cliff Lodge Hotel, Snowbird Ski and Summer Resort in Snowbird, Utah. The conference format consists of a full day of one-on-one meetings and will not be webcast.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.  For more information, visit http://www.abaxis.com.

Contact:

Abaxis, Inc.

Lytham Partners, LLC


Clint Severson

Joe Dorame, Robert Blum and Joe Diaz


Chief Executive Officer

602-889-9700


510-675-6500


 

SOURCE Abaxis, Inc.

Copyright 2014 PR Newswire

1 Year Abaxis, Inc. (delisted) Chart

1 Year Abaxis, Inc. (delisted) Chart

1 Month Abaxis, Inc. (delisted) Chart

1 Month Abaxis, Inc. (delisted) Chart

Your Recent History

Delayed Upgrade Clock